Hvis lægemidlet anvendes under graviditet, eller patienten bliver gravid under behandling med lægemidlet, skal patienten underrettes om den potentielle risiko for fostret.
If the drug is used during pregnancy or if the patient becomes pregnant while receiving this drug, the patient should be apprised of the potential hazard to the foetus.